Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Open accessThe DOI matches its Crossref record; 621 of the 628 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected women have marked insulin resistance, independent of obesity. This article summarizes the state of the science since we last reviewed the field in the Endocrine Reviews in 1997. There is general agreement that obese women with PCOS are insulin resistant, but some groups of lean affected women may have normal insulin sensitivity. There is a post-binding defect in receptor signaling likely due to increased receptor and insulin receptor substrate-1 serine phosphorylation that selectively affects metabolic but not mitogenic pathways in classic insulin target tissues and in the ovary. Constitutive activation of serine kinases in the MAPK-ERK pathway may contribute to resistance to insulin's metabolic actions in skeletal muscle. Insulin functions as a co-gonadotropin through its cognate receptor to modulate ovarian steroidogenesis. Genetic disruption of insulin signaling in the brain has indicated that this pathway is important for ovulation and body weight regulation. These insights have been directly translated into a novel therapy for PCOS with insulin-sensitizing drugs. Furthermore, androgens contribute to insulin resistance in PCOS. PCOS may also have developmental origins due to androgen exposure at critical periods or to intrauterine growth restriction. PCOS is a complex genetic disease, and first-degree relatives have reproductive and metabolic phenotypes. Several PCOS genetic susceptibility loci have been mapped and replicated. Some of the same susceptibility genes contribute to disease risk in Chinese and European PCOS populations, suggesting that PCOS is an ancient trait.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin resistance and hyperinsulinemia, either directly or indirectly, through factors such as adiposity can lead to increase circulating androgen levels (6).”
From Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis (2025) · cites this paper as [6]
In the citing paper
“Androgen excess favors visceral fat deposition and lipid dysfunction with a vicious cycle of worsening of hyperinsulinemia and insulin resistance (6).”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [6]
In the citing paper
“primarily due to hyperinsulinemia resulting from insulin resistance, which increases ovarian androgen production [162, 163].”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [163]
In the citing paper
“Moreover, women who have both obesity and PCOS exhibit a greater level of insulin resistance in comparison to obese persons who do not have PCOS [53].”
In the citing paper
“Consensus is yet to be achieved in lean women with PCOS as IR is not consistently demonstrated (Diamanti-Kandarakis and Dunaif, 2012).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Diamanti-Kandarakis and Dunaif, 2012
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Research works printed but not linked: 5
- Achard, 1921, Le virilisme et son association à l'insuffisance glycolytique (diabète des femmes à barbe), Bull Acad Natl Med (Paris), 86, 51
- Vague, 1947, La différentiation sexuelle. Facteur determinant des formes de l'obesité, Presse Med, 55, 339
- Chereau, 1844, Mémoires pour servir à l'étude des malades ovaires
- Givens, 1992, Historical Overview of the Polycystic Ovary, 3
- Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome; towards a rational approach, 377
Cited by
Items 801–900 of 1,006
Cussen, L., McDonnell, T., Miller, C., McIlroy, M., & O’Reilly, M. (2025) · Reproduction · doi:10.1530/rep-25-0102 · Cited by 23
Barraza-Ortega, E., Gómez‐Gil, B., García-Gasca, T., Lizárraga, D., Díaz, N., & García-Gasca, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178574 · Cited by 21
The pathogenesis, therapeutic targets and drugs of polycystic ovary syndrome
Chen, Y., Sun, X., Xia, X., Chen, K., & Zeng, F. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1722649 · Cited by 21
Kumar, K. D., Huntriss, R., Green, E., Bora, S., & Pettitt, C. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13055 · Cited by 22
“A crucial metabolic complication of PCOS is insulin resistance (IR) which is thought to be a pivotal contributor to the pathogenesis, with 40%–70% of women with PCOS having IR independent of BMI.20 Around 40%–60% of women with PCOS live with obesity, which itself leads to insulin insensitivity, metabolic syndrome, and…”
BackgroundHuo, Y., Ji, S., Yang, H. J., Wu, W., Yu, L., Ren, Y., & Wang, F. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2941 · Cited by 21
“PCOS with insulin resistance is selective and affects metabolism but does not affect the signaling pathway of mitosis (9).”
Sapmaz, T., Şevgin, K., Topkaraoğlu, S., Tekayev, M., Gumuskaya, F., Efendic, F., Pence, M. E., Aktaş, S., Hekimoğlu, G., & İrkörücü, O. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.098 · Cited by 21
Dumesic, D. A., Winnett, C., Lu, G., Grogan, T., Abbott, D. H., Naik, R., & Chazenbalk, G. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.09.324 · Cited by 21
Niu, J., Lu, M.-Y., & Liu, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01122-4 · Cited by 21
“Oligomenorrhea is defined as a menstrual cycle of more than 35 days (usually less than 8 cycles per year), which is a sign of anovulatory cycle [30].”
BackgroundExploring the role of gut microbiota in obesity and PCOS: Current updates and future prospects
Zhang, H., Butoyi, C., Yuan, G., & Jia, J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110781 · Cited by 21
Wang, L., Luo, M., Yu, X., Li, R., Ye, F., Xiong, D., Yan Fang, G. O. N. G., Zheng, M., Liu, W., & Zeng, J. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01405-4 · Cited by 21
“Thus, addressing the issue of obese PCOS is of paramount concern in clinical practice [34].”
BackgroundTargets to treat androgen excess in polycystic ovary syndrome
Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1075511 · Cited by 21
“In addition, insulin resistance and hyperinsulinism enhance ovarian and adrenal androgen secretion in these women [11,12].”
BackgroundThe good, the bad, and the ugly facets of insulin resistance
Kumar, K. V. S. H. (2020) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2019.07.001 · Cited by 21
“PCOD is a complex genetic disease, and themale equivalent of PCOD is early-onset (younger than 35 years) androgenetic alopecia.(9) Nonalcoholic fatty liver disease is another common accompaniment of IR.”
BackgroundSaturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome
González, F., Considine, R. V., Abdelhadi, O. A., Xue, J., & Acton, A. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00213.2021 · Cited by 21
Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
Glintborg, D., Kolster, N. D., Ravn, P., & Andersen, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061455 · Cited by 21
“Insulin resistance is closely associated with obesity [5,6], and obesity is associated with increased risk of type 2 diabetes (T2D) in PCOS [7–9].”
BackgroundHarris, R. A., Archer, K. J., Goodarzi, M. O., York, T. P., Rogers, J., Dunaif, A. E., McAllister, J. M., & Strauss, J. F. (2022) · Gene · doi:10.1016/j.gene.2022.147062 · Cited by 21
Self-citationComputational investigation of four isoquinoline alkaloids against polycystic ovarian syndrome
Moka, M. K., Ankul Singh, S., & Mohan, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2222828 · Cited by 21
“(Diamanti-Kandarakis & Dunaif, 2012).”
Antić, I. B., Ilic, D. S., Bjekić-Macut, J., Bogavac, T., Milutinović, D. V., Kastratović-Kotlica, B., Milic, N. M., Stanojlović, O. P., Andric, Z. G., & Μacut, D. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0775 · Cited by 21
Vela, D., Sopi, R., & Mladenov, M. I. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.04.007 · Cited by 22
Dietary and serum n -3 PUFA and polycystic ovary syndrome: a matched case–control study
Lu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C. (2022) · British Journal of Nutrition · doi:10.1017/s0007114521003007 · Cited by 20
“Therefore, reducing insulin resistance may be beneficial for restoring ovulatory menstrual cycles (37) .”
InfluentialIs cardiorespiratory fitness impaired in PCOS women? A review of the literature
Donà, S., Bacchi, E., & Moghetti, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0599-1 · Cited by 20
“As reported above, PCOS is often characterized by the presence of insulin resistance, with associated hyperinsulinemia, and most patients are overweight or obese [5].”
BackgroundInfluentialWang, F., Dou, P., Wei, W., & Liu, P. J. (2024) · Nutrition & Diabetes · doi:10.1038/s41387-024-00263-9 · Cited by 20
“…the overall effect of HPDs and potential mechanism behind this should be further elucidated beyond the context of intermediate biomarkers and other crucial clinical outcomes, such as the risks of diabetes, cardiovascular disease, ovulatory cycle disturbances, and infertility in patients with PCOS.”
BackgroundKoleva-Tyutyundzhieva, D. I., Ilieva-Gerova, M., Deneva, T., & Orbetzova, M. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199702 · Cited by 20
“It is known to play a pivotal role in the development of both reproductive and metabolic abnormalities [6].”
Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Betlejewska, J., Hubska, J., Roszkowska, Z., Maciejczyk, A., Bachurska, D., Domański, J., Miarka, M., Raszeja‐Wyszomirska, J., Bobrowicz, M., & Ambroziak, U. (2025) · Biomedicines · doi:10.3390/biomedicines13102500 · Cited by 20
“In parallel, insulin acts beyond the ovary; it increases LH pulsatility, promotes adrenal steroidogenesis via P450c17 α , and suppresses hepatic production of sex hormone-binding globulin (SHBG), thereby elevating the concentration of free androgens [114,115].”
Butt, M. A., Shafique, H. M., Mustafa, M., Moghul, N. B., Munir, A., Shamas, U., Tabassum, S., & Kiyani, M. M. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03579-2 · Cited by 20
Lean mass and associated factors in women with PCOS with different phenotypes
Fighera, T. M., dos Santos, B. R., & Spritzer, P. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292623 · Cited by 20
“Indeed, studies of skeletal muscle biopsies from women with PCOS have reported constitutive activation of kinases in the mitogenic MAPK-ERK 1 and 2 pathway, contributing to serine phosphorylation of IRS-1 with consequent inhibition of metabolic signaling in muscle tissue [44–46].”
Changes of insulin receptors in high fat and high glucose diet mice with insulin resistance
Chen, L., Wang, J., Li, X., Mao, Y., & Yan, J. (2023) · Adipocyte · doi:10.1080/21623945.2023.2264444 · Cited by 20
“Some PCOS patients exhibit increased phosphorylation of the serine residues of the IRS-1 molecule, thereby preventing the INSR from exerting its signal transduction function [26].”
BackgroundAssociation between waist circumference and female infertility in the United States
Ke, J., Feng, Y., & Chen, Z. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295360 · Cited by 20
Investigating GABA Neuron–Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS
Sucquart, I. E., Coyle, C. S., Paris, V. R., Prescott, M., Glendining, K. A., Potapov, K., Begg, D. P., Gilchrist, R. B., Walters, K. A., & Campbell, R. E. (2024) · Endocrinology · doi:10.1210/endocr/bqae060 · Cited by 20
Luo, C., Li, Q., Wang, Z., Duan, S., & Ma, Q. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1399969 · Cited by 20
Bo, Y., Zhao, J., Liu, C., & Yu, T. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03594-6 · Cited by 20
Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?
Paschou, S. A., Ioannidis, D., Vassilatou, E., Mizamtsidi, M., Panagou, M., Lilis, D., Tzavara, I., & Vryonidou, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122050 · Cited by 18
“Thus, high birth weight in women with PCOS could have an additive effect on the development of obesity, insulin resistance and hyperandrogenism in adulthood [34].”
BackgroundPotential roles of carnitine in patients with polycystic ovary syndrome: a systematic review
Maleki, V., Vayghan, H. J., Kashani, A., Moradi, F., Vajdi, M., Kheirouri, S., & Alizadeh, M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1576616 · Cited by 20
“Insulin resistance and hyperinsulinemia are caused by increased androgens in patient with PCOS [22].”
BackgroundManousopoulou, A., Al‐Daghri, N. M., Sabico, S., Garay‐Baquero, D. J., Teng, J., Alenad, A. M. H., Alokail, M. S., Athanasopoulos, N., Deligeoroglou, E., Chrousos, G. P., et al. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800184 · Cited by 20
Novel noscapine derivatives stabilize the native state of insulin against fibrillation
Alijanvand, S. H., Christensen, M. H., Christiansen, G., Harikandei, K. B., Salehi, P., Schiøtt, B., Moosavi‐Movahedi, A. A., & Otzen, D. E. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.061 · Cited by 21
Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
Jacewicz‐Święcka, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103367 · Cited by 21
“It is well established that insulin resistance (IR) and compensatory hyperinsulinaemia are central aetiological abnormalities in women with PCOS which lead to the overproduction of ovarian and adrenal androgens and an increase in androgen bioavailability through inhibition of sex hormone-binding globulin (SHBG) secret…”
BackgroundXu, Y., Tang, J., Guo, Q., Xu, Y., Yan, K., Wu, L., Xie, K., Zhu, A., Rong, X., Ye, D., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113587 · Cited by 20
Síndrome de ovario poliquístico
Winnykamien, I., Dalibón, A., & Knoblovits, P. (2017) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/rev.hosp.ital.b.aires.v37i1.842 · Cited by 20
Liu, Y., Fan, H., Hu, J.-Q., Wu, T., & Chen, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13991 · Cited by 21
“4), with significant heterogeneity (I [2] = 82%).”
InfluentialMechanism and recent updates on insulin-related disorders
Kumar, S., Senapati, S., Bhattacharya, N., Bhattacharya, A., Maurya, S. K., Husain, H., Bhatti, J. S., & Pandey, A. K. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i25.5840 · Cited by 21
Parent-of-Origin Effects on Glucose Homeostasis in Polycystic Ovary Syndrome
Kobaly, K., Vellanki, P., Sisk, R. K., Armstrong, L., Lee, J. Y., Lee, J., Hayes, M. G., Urbanek, M., Legro, R. S., & Dunaif, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4338 · Cited by 18
Self-citationPrevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome
Mumm, H., Altinok, M. L., Henriksen, J. E., Ravn, P., Glintborg, D., & Andersen, M. (2016) · Human Reproduction · doi:10.1093/humrep/dew046 · Cited by 20
Özdemir, O., Kurdoğlu, Z., Yıldız, S., Özdemir, P. G., & Yılmaz, E. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.043 · Cited by 20
“…(PCOS) is the most common endocrine disorder among women of reproductive age, and it can be diagnosed is about 5% to 10% of such women (Rasgon et al., 2003; Azziz et al. 2004; Diamanti-Kandarakis and Dunaif 2012; Yildiz et al. 2012; Sahingoz et al., 2013; Annagur et al., 2013; Cakır et al., 2013).”
BackgroundIncreased insulin resistance in men with unexplained infertility
Mansour, R., El-Faissal, Y., Kamel, A., Kamal, O., Aboulserour, G., Aboulghar, M. A., & Fahmy, I. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.08.020 · Cited by 20
“Insulin resistance (IR) has been considered a major contributor to the pathogenesis of chronic oligoovulation or anovulation as well as other metabolic abnormalities in women with polycystic ovary syndrome (PCOS) (Diamanti-Kandarakis and Dunaif, 2012; Rosenfield, 1997).”
BackgroundMetformin improves ovarian insulin signaling alterations caused by fetal programming
Heber, M. F., Ferreira, S. R., Abruzzese, G. A., Raices, T., Pignataro, O. P., Vega, M., & Motta, A. B. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0520 · Cited by 20
Siriesha, Sharma, N., Lugani, Y., Kaur, A., & Ahuja, V. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_490_19 · Cited by 20
“[8] This well explains the various features associated with PCOS like menstrual irregularities and hyperandrogenism, and other metabolic manifestations like central obesity, cardiovascular diseases, hypertension, dyslipidemia, insulin resistance, diabetes, cancers, psychological problems, and obstructive sleep apnea.[…”
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Zeng, X., Zhong, Q., Li, M., Liu, Y., Long, S.-L., Xie, Y., & Mo, Z. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01087-w · Cited by 19
Cao, Y., Li, G., & Ren, Y. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02222-5 · Cited by 19
“From biological and functional perspective, engaging in prolonged periods of sitting behavior increases the likelihood of metabolic dysfunction, that plays an important role in the pathogenesis of PCOS and exacerbates the symptoms of PCOS that in turn may affect perceptions of own functioning and HRQoL [45, 46].”
BackgroundAlhassan, S. M., Elmugadam, A., Elfadil, G. A., Abubaker, N. E., Elfaki, E. M., Hamza, A., Abdalhabib, E. K., & Karar, T. (2023) · International Journal of Women s Health · doi:10.2147/ijwh.s403347 · Cited by 19
The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
Rosenfield, R. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae007 · Cited by 19
Alenezi, S. A., Elkmeshi, N., Alanazi, A., Alanazi, S. T. A., Khan, R. N., & Amer, S. A. K. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164934 · Cited by 19
“A significant proportion of women with PCOS are overweight or obese, with rates reported up to 61% [3], and a substantial number also experience insulin resistance, ranging from 44% to 70% [4].”
BackgroundZhang, B., Wang, J., Shen, S., Liu, J., Sun, J., Gu, T., Zhu, D., & Bi, Y. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1462319 · Cited by 19
Dutkowska, A., Konieczna, A., Breska-Kruszewska, J., Krzyczkowska-Sendrakowska, M., Kowalska, I., & Rachoń, D. (2019) · Endokrynologia Polska · doi:10.5603/ep.a2019.0006 · Cited by 20
Metabolic Syndrome and Myocardial Infarction in Women
Μacut, D., Ognjanovic, S. I., Ašanin, M., Krljanać, G., & Milenković, T. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210610114029 · Cited by 19
Liao, D., Liu, X., Yuan, X., Feng, P., Ouyang, Z., Liu, Y., & Li, C. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1988559 · Cited by 19
Wagner, I. V., Savchuk, I., Sahlin, L., Kulle, A. E., Klöting, N., Dietrich, A., Holterhus, P.-M., Dötsch, J., Blüher, M., & Söder, O. (2022) · Obesity Facts · doi:10.1159/000521571 · Cited by 19
An Overview of Hyperandrogenism in PCOS and the Prospective Underlying Factors
Abinaya, S., Siva, D., Sabitha, R., & Achiraman, S. (2019) · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences · doi:10.26479/2019.0501.18 · Cited by 19
Genazzani, A. D., Battipaglia, C., Rusce, M. L., Prampolini, G., Aio, C., Ricciardiello, F., Foschi, M., Sponzilli, A., Semprini, E., & Petrillo, T. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2341701 · Cited by 20
“Such compensatory hyperinsulinemia has been observed in up to 50–70% of women with PCOS and obesity and in 15–30% of PCOS women with normal weight [5,8].”
Metformin in women with PCOS, CONS
Misso, M. L., & Teede, H. J. (2014) · Endocrine · doi:10.1007/s12020-014-0394-8 · Cited by 19
Sipahi, M., Tokgöz, V. Y., Keskin, Ö., Atasever, M., Menteşe, A., & Demir, S. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1522530 · Cited by 19
Nasser, H. A., AbuelEzz, N. Z., Abdel-Mageed, H. M., & Radwan, R. A. (2019) · Journal of Medical Biochemistry · doi:10.2478/jomb-2019-0012 · Cited by 19
Artimani, T., & Najafi, R. (2020) · Cell Biology International · doi:10.1002/cbin.11367 · Cited by 19
Dehghan, R., Saidijam, M., Mehdizade, M., Shabab, N., Yavangi, M., & Artimani, T. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0468-y · Cited by 19
“Resistance to insulin has been observed in 50–70 % of women with PCOS [10, 15, 16].”
BackgroundPalioura, E., Kandaraki, E., & Diamanti‐Kandarakis, E. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0003 · Cited by 19
“At a molecular level, there is a postbinding defect in receptor signaling likely due to increased receptor and insulin receptor substrate-1 serine phosphorylation [9].”
BackgroundSelf-citationKachhawa, G., Senthil Kumar, K. V., Kulshrestha, V., Khadgawat, R., Mahey, R., & Bhatla, N. (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13971 · Cited by 18
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS
Li, X., Yang, D., Pan, P., Azziz, R., Yang, D., Cheng, Y., & Zhao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873726 · Cited by 18
Jafar, N. K. A., Fan, M., Moran, L., Mansfield, D. R., & Bennett, C. (2025) · Clinical Endocrinology · doi:10.1111/cen.15219 · Cited by 18
“Insulin resistance and hyperinsulinemia can reduce SHBG, leading to increased risk of OSA [11].”
Annie, L., Gurusubramanian, G., & Roy, V. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119409 · Cited by 18
[Proinflammatory cytokines in polycystic ovarian syndrome].
García-Sáenz, M. R., Ferreira‐Hermosillo, A., & Lobaton-Ginsberg, M. (2022) · PubMed Central · Cited by 18
Daghestani, M. H., Alqahtani, H. A., AlBakheet, A., Deery, M. A. A., Awartani, K. A., Daghestani, M. H., Kaya, N., WARSY, A., Coşkun, S., & Çolak, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236941 · Cited by 18
“Altered insulin functions have long been associated with abnormalities in female reproduction [42,43].”
BackgroundXia, L., Shen, Y., Liu, S., & Du, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1174817 · Cited by 18
An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome
Dumesic, D. A., Abbott, D. H., & Chazenbalk, G. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196120 · Cited by 18
Chronically Increased Levels of Circulating Insulin Secondary to Insulin Resistance: A Silent Killer
Fazio, S., Bellavite, P., & Affuso, F. (2024) · Biomedicines · doi:10.3390/biomedicines12102416 · Cited by 18
“For this reason, it has been suggested to treat this syndrome with insulin-sensitizing substances [70,71].”
BackgroundRossetti, R., Strinati, V., Caputi, A., Risi, R., Spizzichini, M. L., Mondo, A., Spiniello, L., Lubrano, C., Giancotti, A., Tuccinardi, D., et al. (2024) · Metabolites · doi:10.3390/metabo14120691 · Cited by 19
Liauchonak, I., Dawoud, F., Riat, Y., Qorri, B., Sambi, M., Jain, J., Kalaydina, R.-V., Mendonza, N., Bajwa, K., & Szewczuk, M. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020575 · Cited by 18
Zhou, W., Hong, Y., Yin, A., Liu, S., Chen, M., Lv, X., Nie, X., Tan, N., & Zhang, Z. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113262 · Cited by 19
Kowalczyk, K., Radosz, P., Barański, K., Pluta, D., Kowalczyk, D., Franik, G., & Madej, P. (2021) · International Journal of Endocrinology · doi:10.1155/2021/8427150 · Cited by 18
“Insulin resistance and hyperinsulinemia seem to play a key role in the development of consecutive stages [3, 4].”
BackgroundMishra, P., Mittal, P., Rani, A., Bharti, R., Agarwal, V., & Suri, J. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_137_22 · Cited by 18
“Indian Journal of Endocrinology and Metabolism ¦ Volume 26 ¦ Issue 3 ¦ May-June 2022 240 hormone binding globulins (SHBGs), which in turn increase the fraction of unbound circulating androgens.[10] These major metabolic and reproductive abnormalities are coupled with altered secretion of several adipose derived peptid…”
BackgroundA Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2015) · Women s Health · doi:10.2217/whe.15.13 · Cited by 18
Ashrafi, M., Sheikhan, F., Arabipoor, A., Rouhana, N. A., Hosseini, R., & Zolfaghari, Z. (2017) · Oman Medical Journal · doi:10.5001/omj.2017.40 · Cited by 18
Metabolic risk factors in adolescent girls with type 1 diabetes
Castro-Correia, C., Silva, R. S., Pinheiro, M. I., Costa, C., & Fontoura, M. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0053 · Cited by 18
Iwata, N., Hasegawa, T., Fujita, S., Nagao, S., Nakano, Y., Nada, T., Nishiyama, Y., Hosoya, T., & Otsuka, F. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.058 · Cited by 18
“It has been considered that the existence of insulin resistance is highly involved in the pathogenesis of PCOS [4].”
BackgroundAl-Gareeb, A. I., Abd-Alamieer, W. S., Al-Kuraishy, H. M., & Al-Maiahy, T. J. (2016) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.14.2.81 · Cited by 18
“Plasma homocysteine levels have been indicated to correspond with blood pressure, body weight and insulin receptor sensitivity, since hypertension, obesity and hyperinsulinemia are habitually experienced elements of PCOS, it appears to be coherent to guess that raised homocysteine levels could be another element of PC…”
BackgroundNormal Metabolic Flexibility despite Insulin Resistance Women with Polycystic Ovary Syndrome
Adamska, A., Karczewska-Kupczewska, M., Nikolajuk, A., Otziomek, E., Górska, M., Kowalska, I., & Straczkowski, M. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0115 · Cited by 17
Baldani, D. P., Skrgatic, L., Ougouag, R., & Kasum, M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1381681 · Cited by 17
“then age-comparable women without PCOS [3,4].”
Lu, Y., Chang, P.-H., Chen, H.-J., Hsueh, Y., Chang, C., Hsu, H.-C., Yang, T., Lin, W., & Chang, H. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70452 · Cited by 19
“12 Moreover, preclinical studies have suggested that GLP-1 and its analogs may directly influence neuroendocrine regulation of reproduction by modulating gonadotropin-releasing hormone and LH secretion via hypothalamic pathways.”
Insulin resistance and coronary microvascular dysfunction: a complex interplay
Magistri, M., Portolan, L., Trevisanello, A., Tosi, F., Locatelli, A., Piana, S., Rubinelli, M., Molinaroli, E., Mantovani, A., Ribichini, F. L., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03068-x · Cited by 17
“IR is characterised by a reduced ability of insulin to mediate its metabolic actions on glucose uptake, glucose production, and lipolysis [7].”
Jain, S., Jain, M., & Shukla, R. C. (2021) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-021-01557-z · Cited by 17
Nikanfar, S., Hamdi, K., Haiaty, S., Samadi, N., Shahnazi, V., Fattahi, A., & Nouri, M. (2022) · Reproductive Biology · doi:10.1016/j.repbio.2022.100633 · Cited by 17
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
McDonnell, T., Cussen, L., McIlroy, M., & O’Reilly, M. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221113140 · Cited by 18
Giannouli, A., Efthymiou, V., Konidari, M., Mani, I., Aravantinos, L., Dourakis, S. P., Antoniou, A., Deligeoroglou, E., & Bacopoulou, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020557 · Cited by 17
Li, J., Chen, S., Qin, R., Liu, X., Fan, L., Wei, M., Wei, J., Lin, J., & Zheng, F. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2231085 · Cited by 17
“IR is a common condition in polycystic ovary syndrome, aggravated by accumulation of adipose tissue associated with hyperandrogen [20], and is involved in the pathogenesis and progression of polycystic ovary syndrome [21].”
BackgroundCircular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome
Jing, T., Wu, Y., Wan, A., Ge, C., Chen, Z., & Du, Y. (2023) · Biomolecules · doi:10.3390/biom13071101 · Cited by 17
Zhuang, J., Wang, S., Wang, Y., Hu, R., & Wu, Y. (2024) · International Journal of Women s Health · doi:10.2147/ijwh.s461950 · Cited by 17
Cavalcante, R. B. D. M., Leão, L. M. C. S. M., Tavares, A. B. W., Lopes, K. G., & Kraemer‐Aguiar, L. G. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2386-9281 · Cited by 17
Dattolo, A., Torres, M., Frías-Toral, E., Paganelli, A., Zhang, M., Madonna, S., Mercurio, L., Cucalón, G., Garbarino, F., Albanesi, C., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06175-1 · Cited by 17
“Among endocrine disorders, the polycystic ovary syndrome (PCOS) is a common comorbidity found in HS women that increases the risk of type 2 diabetes mellitus due to its insulin-resistant nature [34, 62].”
Tian, D., Chen, W., Xu, Q., Li, X., & Lv, Q. (2022) · Minerva Medica · doi:10.23736/s0026-4806.21.07085-3 · Cited by 18
Yuan, C. L., Huang, W. Q., Guo, J. H., Liu, X., Yang, J. Z., Chen, J. J., Wu, Y., Ruan, Y. C., Liu, J. Y., Cui, Y. G., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166242 · Cited by 17
Scannell, N., Moran, L., Mantzioris, E., Cowan, S., & Villani, A. M. (2022) · Metabolites · doi:10.3390/metabo12040311 · Cited by 17
“and polycystic ovarian morphology [1,7,8].”
Ruskovska, T., Morand, C., Bonetti, C. I., Gebara, K. S., Junior, E. L. C., & Milenković, D. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522001027 · Cited by 17
“For example, PI3K-Akt signalling pathway and MAPK signalling pathway are associated with obesity, insulin resistance or polycystic ovary syndrome, all of which are implicative for type 2 diabetes(57,58), while cAMP signalling pathway is involved in both central and peripheral regulation of energy homeostasis(59), card…”
Background
Metadata
- Authors
- Diamanti-Kandarakis, E., & Dunaif, A.
- Affiliations
- Medical School, University of Athens (E.D.-K.), Athens GR-14578, Greece
- Northwestern University (US)
- ORCID
- Dunaif, Andrea
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-10-12
- Volume
- 33
- Issue
- 6
- Pages
- 981-1030
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC5393155
- OpenAlex
- W1967263394
- Semantic Scholar
- b2b7fa060bf61f261edf17bef51cbbbd222742e0
- Cited by
- 1,947
- References
- 628
- Citations by year
- 2026: 183 · 2025: 178 · 2024: 182 · 2023: 221 · 2022: 191 · 2021: 184 · 2020: 136 · 2019: 140 · 2018: 108 · 2017: 97 · 2016: 96 · 2015: 92 · 2014: 91 · 2013: 43 · 2012: 4
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073411)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405, R01HD057223, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, insulin resistance, insulin receptor signaling, MAPK/ERK pathway, skeletal muscle insulin sensitivity, ovarian steroidogenesis, ovulation, brain insulin signaling, body weight regulation, insulin-sensitizing drugs, androgens, developmental origins of health and disease, fetal growth restriction, genetic susceptibility loci, type 2 diabetes risk, lean PCOS
- MeSH terms
- Female, Humans, Insulin Resistance, Phenotype, Polycystic Ovary Syndrome, Reproduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.